| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Save Sight Institute and the 2 Departments of Clinical Ophthalmology, 3 Anatomy and Histology, and 4 Pathology, University of Sydney, New South Wales, Australia.
PURPOSE. The therapeutic potential of TA, an anti-inflammatory glucocorticoid, for the treatment of exudative retinopathy has been examined in several independent clinical studies. The modulation of permeability and adhesion molecule expression of an epithelial cell line has been described in vitro, with the use of cytokines and triamcinolone acetonide (TA). In the current study, the influence of proinflammatory cytokines and TA on permeability and adhesion molecule expression in human choroidal endothelial cells (CECs) was investigated.
METHODS. Human CEC isolates treated with IFN
, TNF
, and TA were evaluated by flow cytometry and immunocytochemistry for expression of intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and major histocompatibility complex (MHC)-I and -II. The effects of IFN, TNF, and TA on paracellular permeability of CEC monolayers were assessed in transendothelial cell resistance (TER) assays.
RESULTS. Both IFN and TNF significantly upregulated expression of ICAM1 and MHC-I on CECs. Expression of VCAM1 was induced after stimulation with both IFN and TNF, whereas expression of MHC-II was induced only by stimulation with IFN. Cytokine-induced expression of ICAM1, MHC-I, and MHC-II antigen by CECs was significantly downregulated by TA. IFN stimulation also increased permeability of CEC monolayers, whereas subsequent TA treatment decreased permeability of CEC monolayers.
CONCLUSIONS. Human CEC isolates provide a useful in vitro model to study choroidal neovascular membrane characteristics and their potential response to pro- and anti-inflammatory agents. In addition, the results indicate that TA has the capacity to reduce adhesion molecule expression and permeability of choroidal vessels in vitro, confirming its potential as a therapeutic agent for treatment of exudative macular degeneration.
This article has been cited by other articles:
|
|
 |
|
  O. Tatar, A. Adam, K. Shinoda, E. Kaiserling, V. Boeyden, C. Claes, C. Eckardt, T. Eckert, G. Pertile, G. B. Scharioth, et al. Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization Arch Ophthalmol, March 1, 2009; 127(3): 275 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Hindman, S. B. Patel, and A. S. Jun Rationale for Adjunctive Topical Corticosteroids in Bacterial Keratitis Arch Ophthalmol, January 1, 2009; 127(1): 97 - 102. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mizuno, A. Matsubara, and Y. Ogura Effect of Posterior Sub-Tenon Administration of Triamcinolone Acetonide on Leukocyte Dynamics in Rat Retinal Microcirculation after Panretinal Photocoagulation Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2127 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mizuno, A. Nishiwaki, H. Morita, T. Miyake, and Y. Ogura Effects of Periocular Administration of Triamcinolone Acetonide on Leukocyte-Endothelium Interactions in the Ischemic Retina Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2831 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Freund, C. M. Klais, C. M. Eandi, M. D. Ober, D. E. Goldberg, J. A. Sorenson, and L. A. Yannuzzi Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol, April 1, 2006; 124(4): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-M Chan, T Y Y Lai, A L Wong, J-P Tong, D T L Liu, and D S C Lam Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br. J. Ophthalmol., March 1, 2006; 90(3): 337 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A C Browning, T Gray, and W M Amoaku Isolation, culture, and characterisation of human macular inner choroidal microvascular endothelial cells Br. J. Ophthalmol., October 1, 2005; 89(10): 1343 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J B Jonas, I Kreissig, and R F Degenring Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration Br. J. Ophthalmol., December 1, 2004; 88(12): 1557 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Yeh, D. V. Bula, J. W. Miller, E. S. Gragoudas, and J. G. Arroyo Expression of Leukocyte Adhesion Molecules in Human Subfoveal Choroidal Neovascular Membranes Treated with and without Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2368 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Yeung, K. P. Chan, S. W. Y. Chiang, C. P. Pang, and D. S. C. Lam The Toxic and Stress Responses of Cultured Human Retinal Pigment Epithelium (ARPE19) and Human Glial Cells (SVG) in the Presence of Triamcinolone Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5293 - 5300. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
